PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a prospective, randomized, open-label, two-arm phase 2 trial that will evaluate whether the use of Pulsed Low-Dose-Rate radiation technique, as compared to standard radiation, is associated with reduced rates of clinically significant esophagitis during and following chemoradiation.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Rak przełyku w stadium II-IVb (jeśli IVb, tylko z ograniczonymi przerzutami)
- •Leczenie chemią poprzedzające, planowana chemio-radioterapia i możliwe usunięcie przełyku
- •Ogólny stan zdrowia pozwalający na leczenie (skala ECOG 0-2)
- •Wystarczająca liczba krwinek i płytek w krwi
- •Prawidłowa funkcja nerek i wątroby
- •Kobiety w wieku rozrodczym: ujemny test ciążowy
- •Zdolność zrozumienia informacji o badaniu i chęć uczestnictwa
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 28, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Froedtert & the Medical College of Wisconsin
Milwaukee, United States
Trial contact
Medical College of Wisconsin Cancer Center Clinical Trials Office
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/29/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.